Effect of a chloride channel inhibitor, 5-nitro-2-(3-phenylpropylamino)- benzoate, on ovarian cancer cell migration

Clinical Laboratory

Volumn 57, Issue 7-8, 2011, Pages 543-550

  Yu, Zhan ^a   Zhang, Zhi Xu ^a   Li, Shenglei ^a   Gao, Jianbo ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

AKT1; Cell migration; Chloride channel; ERK1 2; Ovarian cancer

Indexed keywords

5 NITRO 2 (PHENYLPROPYLAMINO)BENZOIC ACID; CHLORIDE CHANNEL BLOCKING AGENT; PROTEIN KINASE B; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CELL MIGRATION; CELL VIABILITY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN PHOSPHORYLATION; SERUM; SIGNAL TRANSDUCTION; TIME;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; CELL LINE, TUMOR; CELL MOVEMENT; CHLORIDE CHANNELS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITROBENZOATES; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SERUM; SIGNAL TRANSDUCTION;

EID: 80051739950     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gómez-Raposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A. Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol 2010;118:88-92.
2. Cho KR, Shih IeM. Ovarian cancer. Annu Rev Pathol 2009;4:287-313.
3. Soslow RA. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol 2008;27:161-74. (Pubitemid 351450675)
4. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tu-mors. Curr Opin Cell Biol 2005;17:559-64.
5. Schwab A. Function and spatial distribution of ion channels and transporters in cell migration. Am J Physiol Renal Physiol 2001;280:F739-47.
6. Ernest NJ, Weaver AK, Van Duyn LB, Sontheimer HW. Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells. Am J Physiol Cell Physiol 2005;288:C1451-60.
7. Mao J, Wang L, Fan A, et al. Blockage of volume-activated chloride channels inhibits migration of nasopharyngeal carcinoma cells. Cell Physiol Biochem 2007;19:249-58. (Pubitemid 46701500)
8. Mao JW, Wang LW, Jacob T, et al. Involvement of regulatory volume decrease in the migration of nasopharyngeal carcinoma cells. Cell Res 2005;15:371-8. (Pubitemid 41653931)
9. Soroceanu L, Manning TJ Jr, Sontheimer H. Modulation of glioma cell migration and invasion using Cl- and K+ ion channel blockers. J Neurosci 1999;19:5942-54. (Pubitemid 29327929)
10. Menegazzi R, Busetto S, Decleva E, Cramer R, Dri P, Patriarca P. Triggering of chloride ion efflux from human neutrophils as a novel function of leukocyte beta 2 integrins: relationship with spreading and activation of the respiratory burst. J Immunol 1999;162:423-34. (Pubitemid 29018950)
11. Zheng ZZ, Liu ZX. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration. Int J Biochem Cell Biol 2007;39:340-8.
12. Gentilini D, Busacca M, Di Francesco S, Vignali M, Viganò P, Di Blasio AM. PI3K/Akt and ERK1/2 signaling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol Hum Reprod 2007;13:317-22. (Pubitemid 47061642)
13. Jiang Q, Zhou C, Bi Z, Wan Y. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther 2006;22:93-102. (Pubitemid 43742945)
14. Mizutani K, Ito H, Iwamoto I, et al. Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage- independent growth. Oncogene 2007;26:7122-31. (Pubitemid 350059675)
15. Ray RM, Vaidya RJ, Johnson LR. MEK/ERK regulates adher-ens junctions and migration through Rac1. Cell Motil Cytoskel-eton 2007;64:143-56.
16. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-74.
17. Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in endothelial cell and angiogenesis. Cell Cycle 2006;5:512-8.
18. Ransom CB, O'Neal JT, Sontheimer H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 2001;21:7674-83. (Pubitemid 32904966)
19. Conti M. Targeting ion channels for new strategies in cancer diagnosis and therapy. Curr Clin Pharmacol 2007;2:135-44. (Pubitemid 46813422)
20. Suh KS, Yuspa SH. Intracellular chloride channels: critical mediators of cell viability and potential targets for cancer therapy. Curr Pharm Des 2005;11:2753-64. (Pubitemid 41051882)
21. Dahl SG, Sylte I, Ravna AW. Structures and models of transporter proteins. J Pharmacol Exp Ther 2004;309:853-60. (Pubitemid 38669671)
22. Ehring GR, Osipchuk YV, Cahalan MD. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells. J Gen Physiol 1994;104:1129-61.
23. Darby M, Kuzmiski JB, Panenka W, Feighan D, MacVicar BA. ATP released from astrocytes during swelling activates chlo-ride channels. J Neurophysiol 2003;89:1870-7. (Pubitemid 36444243)
24. Crépel V, Panenka W, Kelly ME, MacVicar BA. Mitogen-activated protein and tyrosine kinases in the activation of astrocyte volume-activated chloride current. J Neurosci 1998;18:1196-206. (Pubitemid 28082406)
25. Yu WF, Zhao YL, Wang K, Dong MM. Inhibition of cell proliferation and arrest of cell cycle progression by blocking chloride channels in human laryngeal cancer cell line Hep-2. Neoplasma 2009;56:224-9.
26. Gautam M, Gojova A, Barakat AI. Flow-activated ion channels in vascular endothelium. Cell Biochem Biophys 2006;46:277-84. (Pubitemid 46202581)
27. d'Anglemont de Tassigny A, Berdeaux A, Souktani R, Henry P, Ghaleh B. The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2. Eur J Heart Fail 2008;10:39-46.